SABS logo

SAB Biotherapeutics, Inc. (SABS)

Profile

Full Name

SAB Biotherapeutics, Inc.

Ticker

NASDAQ: SABS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 9, 2021

Indexes

Not included

Website

https://www.sabbiotherapeutics.com

Employees

63

Key Details

Price

$3.25(0.00%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$1.32M(-40.94% YoY)

Annual EPS

-$3.68(51.81% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.25
    SABS price is $3.25

    30-Day Relative Volume

    0.71
    SABS 30-day relative volume is 0.71

    Price Performance

    Price 1-Day Change

    0%
    SABS price is unchanged today

    Price YTD Change

    -14.34%
    SABS price is down -14.34% since January 1st

    Price 1-Year Change

    -19.55%
    SABS price is down -19.55% year-on-year

    Price 3-Year Change

    -66.15%
    SABS price is down -66.15% over the past 3 years

    Price Range

    Price All-Time High

    $129.00
    SABS price is currently -97.48% below its historical high of $129.00

    Price 3-Year Low

    $1.00
    SABS price is currently +225.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $33.84M
    SABS market cap is $33.84 million

    Market Cap 3-Year Change

    -18.09%
    SABS market cap is down -18.09% over the past 3 years

    Market Cap All-Time High

    $488.66M
    SABS market cap is currently -93.08% below its historical high of $488.66 million

    Market Cap Sector Percentile

    28.55%
    SABS market cap is higher than 28.55% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +12.8%
    SABS shares outstanding is up +12.8% year-on-year

    Shares Outstanding 3-Year Change

    +141.94%
    SABS shares outstanding is up +141.94% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.82
    SABS beta is 0.82

    200-day SMA

    $2.05
    SABS price is currently +58.24% above its 200-day simple moving average

    50-day SMA

    $2.43
    SABS price is currently +33.92% above its 50-day simple moving average

    14-Day RSI

    72.25
    SABS 14-day relative strength index is 72.25

    Volume

    0.71
    SABS 30-day relative volume is 0.71

    ATR

    $0.22
    SABS average true range is $0.22

    10-day Historical Volatility

    47.13%
    SABS 10-day historical volatility is 47.13%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.32M
    SABS annual revenue is $1.32 million

    Revenue Analysts Estimate

    $166.67K
    SABS annual revenue is currently +693.42% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    -40.94%
    SABS annual revenue is down -40.94% year-on-year

    Revenue Sector Percentile

    37.95%
    SABS annual revenue is higher than 37.95% of companies in Healthcare sector

    EPS

    EPS

    -$3.68
    SABS annual earnings per share is -$3.68

    EPS Analysts Estimate

    -$1.95
    SABS annual earnings per share is currently -89.32% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +51.81%
    SABS annual earnings per share is up +51.81% year-on-year

    EPS Sector Percentile

    25.97%
    SABS annual earnings per share is higher than 25.97% of companies in Healthcare sector

    Profit

    Gross Profit

    -$3.47M
    SABS annual gross profit is -$3.47 million

    Gross Margin

    -262.42%
    SABS annual gross profit margin is -262.42%

    Operating Profit

    -$42.91M
    SABS annual operating income is -$42.91 million

    Operating Margin

    -3244.90%
    SABS annual operating profit margin is -3244.90%

    Net Income

    -$34.11M
    SABS annual net profit is -$34.11 million

    Net Margin

    -2579.05%
    SABS annual net profit margin is -2579.05%

    Expenses

    Total Expenses

    $42.91M
    SABS annual total expenses is $42.91 million

    Operating Expenses

    $42.91M
    SABS annual total operating expenses is $42.91 million

    Cost Of Goods Sold

    $4.79M
    SABS annual cost of goods sold is $4.79 million

    Selling, General & Administrative Expenses

    $13.98M
    SABS annual SG&A is $13.98 million

    Depreciation & Amortization

    $4.79M
    SABS annual D&A is $4.79 million

    Interest Expense

    $318.40K
    SABS annual interest expense is $318.40 thousand

    Income Tax

    $0.00
    SABS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$33.79M
    SABS annual earnings before interest & taxes is -$33.79 million

    EBITDA

    -$28.99M
    SABS annual EBITDA is -$28.99 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $46.06M
    SABS annual total assets is $46.06 million

    Non Current Assets

    $20.40M
    SABS annual long term assets is $20.40 million

    Current Assets

    $23.79M
    SABS annual total current assets is $23.79 million

    Cash and Cash Equivalents

    $8.90M
    SABS annual cash & cash equivalents is $8.90 million

    Accounts Receivable

    -
    SABS annual accounts receivable value is unknown

    Inventory

    $0.00
    SABS annual inventory is $0.00

    Liabilities

    Total Liabilities

    $20.09M
    SABS annual total liabilities is $20.09 million

    Long Term Liabilities

    $10.25M
    SABS annual total long term liabilities is $10.25 million

    Current Liabilities

    $7.98M
    SABS annual current liabilities is $7.98 million

    Accounts Payable

    $1.69M
    SABS annual accounts payable is $1.69 million

    Debt

    Total Debt

    $4.67M
    SABS annual total debt is $4.67 million

    Total Debt 1-Year Change

    -20.96%
    SABS annual total debt is down -20.96% year-on-year

    Long Term Debt

    $3.86M
    SABS annual long term debt is $3.86 million

    Short Term Debt

    $811.80K
    SABS annual short term debt is $811.80 thousand

    Equity & Capital

    Shareholders Equity

    $25.97M
    SABS annual stockholders equity is $25.97 million

    Book Value

    $25.97M
    SABS annual book value is $25.97 million

    Retained Earnings

    -$124.17M
    SABS annual retained earnings is -$124.17 million

    Working Capital

    $15.81M
    SABS annual working capital is $15.81 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$34.29M
    SABS annual cash from operations is -$34.29 million

    Cash From Operations 1-Year Change

    -36.52%
    SABS annual cash from operations is down -36.52% year-on-year

    Cash From Investing

    -$11.96M
    SABS annual cash from investing is -$11.96 million

    Cash From Investing 1-Year Change

    -7733.86%
    SABS annual cash from investing is down -7733.86% year-on-year

    Cash From Financing

    -$1.17M
    SABS annual cash from financing is -$1.17 million

    Cash From Financing 1-Year Change

    -101.76%
    SABS annual cash from financing is down -101.76% year-on-year

    CAPEX

    CAPEX

    $337.30K
    SABS annual capital expenditures is $337.30 thousand

    CAPEX 1-Year Change

    +71.04%
    SABS annual capital expenditures is up +71.04% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$34.63M
    SABS annual free cash flow is -$34.63 million

    Free Cash Flow 1-Year Change

    -36.78%
    SABS annual free cash flow is down -36.78% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -262.42%
    SABS annual gross profit margin is -262.42%

    Operating Margin

    -3244.90%
    SABS annual operating profit margin is -3244.90%

    Net Margin

    -2579.05%
    SABS annual net profit margin is -2579.05%

    ROA & ROE

    ROA

    -52.47%
    SABS annual return on assets is -52.47%

    ROE

    -81.92%
    SABS annual return on equity is -81.92%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    SABS price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    SABS price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    2.82
    SABS price to book ratio is 2.82

    PB Ratio Sector Percentile

    62.23%
    SABS price to book ratio is higher than 62.23% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    295.00
    SABS price to sales ratio is 295.00

    PS Ratio Sector Percentile

    93.85%
    SABS price to sales ratio is higher than 93.85% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $34.54M
    SABS enterprise value is $34.54 million

    Enterprise Value Sector Percentile

    34.32%
    SABS enterprise value is higher than 34.32% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.90
    SABS EV/EBITDA is -0.90

    EV/EBITDA Sector Percentile

    49.14%
    SABS EV/EBITDA is higher than 49.14% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.98
    SABS annual current ratio is 2.98

    Quick Ratio

    2.98
    SABS annual quick ratio is 2.98

    Leverage

    Debt To Equity

    0.18
    SABS annual debt to equity ratio is 0.18

    Interest Coverage Ratio

    -106.11
    SABS annual interest coverage ratio is -106.11

    Risk & Stability

    F-Score

    -
    SABS piotroski f-score value is unknown

    Altman Z-Score

    -4.74
    SABS altman z-score is -4.74

    Analyst ratings

    Recent major analysts updates

    Sep 19, 25 Chardan Capital
    Buy
    Sep 17, 25 Leerink Partners
    Outperform
    Aug 8, 25 Chardan Capital
    Buy
    Jul 22, 25 HC Wainwright & Co.
    Buy
    May 15, 25 Chardan Capital
    Buy
    Apr 1, 25 HC Wainwright & Co.
    Buy
    Apr 1, 25 Chardan Capital
    Buy
    Jan 29, 25 HC Wainwright & Co.
    Buy
    Jan 29, 25 Chardan Capital
    Buy
    Nov 7, 24 Chardan Capital
    Buy

    Institutional Ownership

    Screeners with SABS included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for SAB Biotherapeutics, Inc.?
    • Does SAB Biotherapeutics, Inc. pay dividends?
    • What sector is SAB Biotherapeutics, Inc. in?
    • What industry is SAB Biotherapeutics, Inc. in?
    • What country is SAB Biotherapeutics, Inc. based in?
    • When did SAB Biotherapeutics, Inc. go public?
    • Is SAB Biotherapeutics, Inc. in the S&P 500?
    • Is SAB Biotherapeutics, Inc. in the NASDAQ 100?
    • Is SAB Biotherapeutics, Inc. in the Dow Jones?
    • When was SAB Biotherapeutics, Inc.'s last earnings report?
    • When does SAB Biotherapeutics, Inc. report earnings?

    What is the ticker symbol for SAB Biotherapeutics, Inc.?

    The ticker symbol for SAB Biotherapeutics, Inc. is NASDAQ:SABS

    Does SAB Biotherapeutics, Inc. pay dividends?

    No, SAB Biotherapeutics, Inc. does not pay dividends

    What sector is SAB Biotherapeutics, Inc. in?

    SAB Biotherapeutics, Inc. is in the Healthcare sector

    What industry is SAB Biotherapeutics, Inc. in?

    SAB Biotherapeutics, Inc. is in the Biotechnology industry

    What country is SAB Biotherapeutics, Inc. based in?

    SAB Biotherapeutics, Inc. is headquartered in United States

    When did SAB Biotherapeutics, Inc. go public?

    SAB Biotherapeutics, Inc.'s initial public offering (IPO) was on February 9, 2021

    Is SAB Biotherapeutics, Inc. in the S&P 500?

    No, SAB Biotherapeutics, Inc. is not included in the S&P 500 index

    Is SAB Biotherapeutics, Inc. in the NASDAQ 100?

    No, SAB Biotherapeutics, Inc. is not included in the NASDAQ 100 index

    Is SAB Biotherapeutics, Inc. in the Dow Jones?

    No, SAB Biotherapeutics, Inc. is not included in the Dow Jones index

    When was SAB Biotherapeutics, Inc.'s last earnings report?

    SAB Biotherapeutics, Inc.'s most recent earnings report was on March 27, 2025

    When does SAB Biotherapeutics, Inc. report earnings?

    The date for SAB Biotherapeutics, Inc.'s next earnings report has not been announced yet
    On this page